Works matching DE "APIXABAN"

Results: 679

Efficacy and Safety of a DOAC Compared to Unfractionated Heparin and A Low Molecular Weight Heparin in the Prevention of Thromboembolism in Hematopoietic Stem Cell Transplant Recipients.

Published in:

IJ Pharmaceutical Research (IJPR), 2024, v. 23, n. 1, p. 1, doi. 10.5812/ijpr-143213

By:

Azimi, Saeed;
Hajifathali, Abbas;
Parkhideh, Sayeh;
Salamzadeh, Jamshid;
Rahmati-Kamel, Bardia;
Dastan, Farzaneh;
Mehdizadeh, Mahshid;
Abiyarghamsari, Mahdiye;
Tavakoli-Ardakani, Maria

Publication type:

Article

In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.

Published in:

Annals of Internal Medicine, 2025, v. 178, n. 5, p. JC57, doi. 10.7326/ANNALS-25-01488-JC

By:

Mansoor, Hend;
Elgendy, Islam Y.

Publication type:

Article

In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.

Published in:

Annals of Internal Medicine, 2025, v. 178, n. 5, p. JC56, doi. 10.7326/ANNALS-25-01330-JC

By:

Alberts, Mark J.

Publication type:

Article

Carotid free-floating thrombus treated with apixaban: report of a case and review of literature.

Published in:

Revista Mexicana de Neurociencia, 2020, v. 21, n. 1, p. 27, doi. 10.24875/rmn.m20000075

By:

Soto-Rincón, Carlos A.;
Castillo-Torres, Sergio A.;
Gonzalez-Aquines, Alejandro;
Farías-Navarro, Iris C.;
Escobar-Valdivia, Emmanuel J.;
García-Valadez, Erik A.;
Chávez-Luévanos, Beatriz E.;
Góngora-Rivera, Fernando

Publication type:

Article

Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban: Cross-Sectional Survey of Atrial Fibrillation Patients.

Published in:

Annals of Family Medicine, 2023, v. 21, p. 1

By:

Tarn, Derjung;
Shih, Kevin;
Schwartz, Janice

Publication type:

Article

Understanding Reasons for Nonadherence to the Direct Oral Anticoagulant (DOAC) Apixaban for Atrial Fibrillation.

Published in:: Annals of Family Medicine, 2022, v. 20, p. 82
Publication type:: Article

Clinical outcomes according to dose reduction criteria of apixaban in Japanese elderly patients with atrial fibrillation: J-ELD AF Registry subanalysis.

Published in:

Heart & Vessels, 2021, v. 36, n. 7, p. 1035, doi. 10.1007/s00380-021-01777-3

By:

Akao, Masaharu;
Yamashita, Takeshi;
Suzuki, Shinya;
Okumura, Ken;
J-ELD AF Investigators;
Sakuma, Ichiro;
Ajioka, Masayoshi;
Kusano, Kengo;
Ohki, Takahiro;
Kimura, Takeshi;
Asakawa, Tetsuya;
Okabe, Masaaki;
Ogimoto, Akiyoshi;
Ikeda, Takanori;
Nishida, Taku;
Mizukami, Akira;
Tabuchi, Toshifumi;
Suzuki, Yasushi;
Ako, Junya;
Takatsuki, Seiji

Publication type:

Article

Edoxaban suppresses the progression of atrial fibrosis and atrial fibrillation in a canine congestive heart failure model.

Published in:

Heart & Vessels, 2019, v. 34, n. 8, p. 1381, doi. 10.1007/s00380-019-01377-2

By:

Tsujino, Yasushi;
Sakamoto, Tamotsu;
Kinoshita, Koshi;
Nakatani, Yosuke;
Yamaguchi, Yoshiaki;
Kataoka, Naoya;
Nishida, Kunihiro;
Kinugawa, Koichiro

Publication type:

Article

Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System.

Published in:

Heart & Vessels, 2017, v. 32, n. 3, p. 309, doi. 10.1007/s00380-016-0864-4

By:

Idemoto, Yoshiaki;
Miura, Shin-ichiro;
Norimatsu, Kenji;
Suematsu, Yasunori;
Hitaka, Yuka;
Shiga, Yuhei;
Morii, Joji;
Imaizumi, Satoshi;
Kuwano, Takashi;
Iwata, Atsushi;
Zhang, Bo;
Ogawa, Masahiro;
Saku, Keijiro

Publication type:

Article

Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction.

Published in:

2016

By:

Mano, Yoshinori;
Koide, Kimi;
Sukegawa, Hiroaki;
Kodaira, Masaki;
Ohki, Takahiro

Publication type:

Report

The continuous challenge of antithrombotic strategies in diabetes: focus on direct oral anticoagulants.

Published in:

Acta Diabetologica, 2019, v. 56, n. 12, p. 1247, doi. 10.1007/s00592-019-01426-2

By:

Pomero, Fulvio;
Dentali, Francesco;
Mumoli, Nicola;
Salomone, Pietro;
Tangianu, Flavio;
Desideri, Giovambattista;
Mastroiacovo, Daniela

Publication type:

Article

Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221142220

By:

Reyes, Jorge L.;
Herzog, Charles A.;
Yan, Heng;
Roetker, Nicholas S.;
Wetmore, James B.

Publication type:

Article

Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221128124

By:

Brochu, Dannick;
St-Arnaud, Amélie;
Marchand, Louis-Étienne;
Voisine, Pierre;
Méthot, Julie

Publication type:

Article

Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation.

Published in:

2021

By:

Park, Susin;
Je, Nam Kyung

Publication type:

journal article

Comparison of Anticoagulants for Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Pilot Study.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2020, v. 25, n. 6, p. 523, doi. 10.1177/1074248420929483

By:

Chapin, Todd W.;
Leedahl, David D.;
Brown, Andrew B.;
Pasek, Andrew M.;
Sand, Mitchell G.;
Loy, Maari L.;
Dyke, Cornelius M.

Publication type:

Article

Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.

Published in:

2019

By:

Kattoor, Ajoe John;
Pothineni, Naga Venkata;
Goel, Akshay;
Syed, Mahanazuddin;
Syed, Shorabuddin;
Paydak, Hakan;
Mehta, Jawahar L.

Publication type:

journal article

Evaluation of the Effect of Apixaban on INR in the Inpatient Population.

Published in:

2019

By:

Kovacevic, Mary P.;
Lupi, Kenneth E.;
Wong, Adrian;
Gilmore, James F.;
Malloy, Rhynn

Publication type:

journal article

Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia.

Published in:

2018

By:

Gomez-Lumbreras, Ainhoa;
Cortes, Jordi;
Morros, Rosa;
Giner-Soriano, Maria;
Quijada-Manuitt, M. Angeles

Publication type:

journal article

Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data.

Published in:

Turkish Journal of Medical Sciences, 2022, v. 52, n. 4, p. 948, doi. 10.55730/1300-0144.5395

By:

ASLAN, Onur;
YILDIRIM, Sinan

Publication type:

Article

MODERN ORAL ANTICOAGULANT TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE: INSIGHTS FROM THE CLINICAL PRACTICE.

Published in:

Farmacia, 2018, v. 66, n. 6, p. 972, doi. 10.31925/FARMACIA.2018.6.7

By:

ŢICA, OTILIA ANCA;
ŢICA, OVIDIU;
ANTAL, LIANA;
HATOS, ADRIAN;
POPESCU, MIRCEA IOACHIM;
STOIAN, ANCA PANTEA;
BRATU, OVIDIU GABRIEL;
GĂMAN, MIHNEA-ALEXANDRU;
PIŢURU, SILVIU MIREL;
DIACONU, CAMELIA CRISTINA

Publication type:

Article

METHOD DEVELOPMENT AND VALIDATION OF APIXABAN USING RP-HPLC METHOD AND ITS STRESS STABILITY STUDIES.

Published in:

International Journal of Chemical & Pharmaceutical Analysis, 2017, v. 5, n. 1, p. 1

By:

Haque, Akiful;
Soundharya, Rayanni;
Venu, Julakanti;
Monika, Malipeddi Lakshmi;
Bakshi, Vasudha

Publication type:

Article

Optimizing warfarin dosing for patients with atrial fibrillation using machine learning.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-55110-9

By:

Petch, Jeremy;
Nelson, Walter;
Wu, Mary;
Ghassemi, Marzyeh;
Benz, Alexander;
Fatemi, Mehdi;
Di, Shuang;
Carnicelli, Anthony;
Granger, Christopher;
Giugliano, Robert;
Hong, Hwanhee;
Patel, Manesh;
Wallentin, Lars;
Eikelboom, John;
Connolly, Stuart J.

Publication type:

Article

Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-50347-2

By:

Martinez-Sanchez, Julia;
Castrillo, Leticia;
Jerez, Didac;
Torramade-Moix, Sergi;
Palomo, Marta;
Mendieta, Guiomar;
Zafar, M. Urooj;
Moreno-Castaño, Ana Belén;
Sanchez, Pablo;
Badimon, Juan Jose;
Diaz-Ricart, Maribel;
Escolar, Gines;
Roqué, Mercè

Publication type:

Article

Reversal Agents for Oral Anticoagulant Rivaroxaban.

Published in:

Journal of the Chemical Society of Pakistan, 2018, v. 40, n. 5, p. 974

By:

Fattah, Tanzeela Abdul;
Saeed, Aamer;
Larik, Fayaz Ali;
Channar, Pervaiz Ali

Publication type:

Article

Effectiveness of prophylactic antibacterial drugs for patients with liver cirrhosis and upper gastrointestinal bleeding: a systematic review and meta-analysis.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1324848

By:

Zhuo Wang;
Han-Shuo Hu;
Li-Mei Zhao;
Yu Li;
Xiao-Dong Liu

Publication type:

Article

The Prescription trends and dosing appropriateness analysis of novel oral anticoagulants in ischemic stroke patients: a retrospective study of 9 cities in China.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1304139

By:

Mingfen Wu;
Hailun Jiang;
Kefu Yu;
Zhigang Zhao;
Bin Zhu

Publication type:

Article

Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation.

Published in:

Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1344828

By:

Yang-Qi Pan;
Lu-Shen Jin;
Sang Qian;
Ting Jiang;
Zhe-Ning Wang;
Yi-Lian Chen;
Yi-Xuan Qiu;
Yi-Hao Wu;
Jia-Yang Fu;
Ling Li;
Yuan-Nan Lin;
Yue-Chun Li

Publication type:

Article

In vivo evaluation of the pharmacokinetic interactions between almonertinib and rivaroxaban, almonertinib and apixaban.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1263975

By:

Zhi Wang;
Ying Li;
Xueru He;
Yuhao Fu;
Yajing Li;
Xin Zhou;
Zhanjun Dong

Publication type:

Article

Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00480

By:

Villari, Ambra;
Giurdanella, Giovanni;
Bucolo, Claudio;
Drago, Filippo;
Salomone, Salvatore

Publication type:

Article

Comparison of Low- Versus High-Dose Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Factor Xa Inhibitor--Associated Bleeding: A Retrospective Study.

Published in:

Journal of Intensive Care Medicine, 2021, v. 36, n. 5, p. 597, doi. 10.1177/0885066620916706

By:

Wilsey, H. Andrew;
Bailey, Abby M.;
Schadler, Aric;
Davis, George A.;
Nestor, Melissa;
Pandya, Komal

Publication type:

Article

Four-Factor Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants.

Published in:

Journal of Intensive Care Medicine, 2021, v. 36, n. 1, p. 58, doi. 10.1177/0885066619882909

By:

Zada, Ilanit;
Shan Wang;
Akerman, Meredith;
Hanna, Adel

Publication type:

Article

Correction.

Published in:: 2023
Publication type:: Correction Notice

Payer formulary tier increases of apixaban: how patients respond and potential implications.

Published in:

Current Medical Research & Opinion, 2023, v. 39, n. 8, p. 1093, doi. 10.1080/03007995.2023.2232636

By:

Deitelzweig, Steven;
Terasawa, Emi;
Atreja, Nipun;
Kang, Amiee;
Hines, Dionne M.;
Dhamane, Amol D.;
Hagan, Melissa;
Noman, Ahmed;
Luo, Xuemei

Publication type:

Article

Differences In Gastrointestinal Safety Profiles Among Novel Oral Anticoagulants: Evidence From A Network Meta-Analysis.

Published in:

Clinical Epidemiology, 2019, v. 11, p. 911, doi. 10.2147/CLEP.S219335

By:

Guo, Wen-Qin;
Chen, Xie-Hui;
Tian, Xiao-Yuan;
Li, Lang

Publication type:

Article

Anticoagulant drug utilization pattern and their cost analysis: a retrospective study from Saudi Arabia.

Published in:

Journal of Pharmaceutical Health Services Research, 2020, v. 11, n. 4, p. 411, doi. 10.1111/jphs.12382

By:

Ali, Mohammad Daud;
Ahmad, Ayaz;
Banu, Nuzhat;
Patel, Munfis;
Ghosn, Sherihan Ahmad;
Eltrafi, Zainab

Publication type:

Article

Comparison of healthcare costs among patients with non‐valvular atrial fibrillation treated with warfarin who switched to a novel oral anticoagulant.

Published in:

Journal of Pharmaceutical Health Services Research, 2020, v. 11, n. 2, p. 133, doi. 10.1111/jphs.12352

By:

Franchino‐Elder, Jessica;
Gilligan, Adrienne;
Song, Xue;
Hartaigh, Briain O;
Henriques, Caroline;
Sainski‐Nguyen, Amy;
Wang, Cheng

Publication type:

Article

Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series.

Published in:

2018

By:

Schultz, Nina Haagenrud;
Lundblad, Runar;
Holme, Pål Andre

Publication type:

journal article

Does amiodarone impact on apixaban levels? The effect of amiodarone on apixaban level among Thai patients with non-valvular Atrial Fibrillation.

Published in:

PLoS ONE, 2024, v. 19, n. 1, p. 1, doi. 10.1371/journal.pone.0295511

By:

Limcharoen, Sutee;
Limprasert, Sarawuth;
Boonmuang, Pornwalai;
Pongchaidecha, Manat;
Suphanklang, Juthathip;
Saelim, Weerayuth;
Santimaleeworagun, Wichai;
Pimsi, Piyarat

Publication type:

Article

Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients.

Published in:

PLoS ONE, 2023, v. 18, n. 5, p. 1, doi. 10.1371/journal.pone.0285412

By:

Firth, Christine;
Shamoun, Fadi;
Apolinario, Michael;
Lim, Elisabeth S.;
Zhang, Nan;
Keddis, Mira T.

Publication type:

Article

Comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban in dogs.

Published in:

Journal of Veterinary Internal Medicine, 2024, v. 38, n. 6, p. 3242, doi. 10.1111/jvim.17216

By:

Lynch, Alex M.;
Ruterbories, Laura K.;
Zhu, Yao;
Fialkiewicz, Frank;
Papich, Mark G.;
Brooks, Marjory B.;
Goggs, Robert

Publication type:

Article

COVID-19 epidemic: anticoagulants treatments, another victim.

Published in:

Acta Cardiologica, 2021, v. 76, n. 2, p. 222, doi. 10.1080/00015385.2020.1810916

By:

Lapostolle, Frédéric;
Vianu, Isabelle;
Petrovic, Tomislav;
Adnet, Frédéric

Publication type:

Article

Apixaban vs Enoxaparin for Postsurgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study.

Published in:

AUANews, 2022, v. 27, n. 10, p. 18

By:

Westerman, Mary E.;
Bree, Kelly K.;
Msaouel, Pavlos;
Kukreja, Janet Baack;
Mantaring, Cheryl;
Rukundo, Innocent;
Gonzalez, Martha Garcia;
Gregg, Justin R.;
Casteel, Kelly N.;
Matin, Surena F.

Publication type:

Article

Prevalence and Knowledge of Potential Interactions Between Over‐the‐Counter Products and Apixaban.

Published in:

Journal of the American Geriatrics Society, 2020, v. 68, n. 1, p. 155, doi. 10.1111/jgs.16193

By:

Tarn, Derjung M.;
Barrientos, Maureen;
Wang, Angel Y.;
Ramaprasad, Abhijit;
Fang, Margaret C.;
Schwartz, Janice B.

Publication type:

Article

Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation.

Published in:

Journal of the American Geriatrics Society, 2019, v. 67, n. 9, p. 1902, doi. 10.1111/jgs.15982

By:

Sukumar, Smrithi;
Gulilat, Markus;
Linton, Bradley;
Gryn, Steven E.;
Dresser, George K.;
Alfonsi, Jeffrey E.;
Schwarz, Ute I.;
Kim, Richard B.;
Schwartz, Janice B.

Publication type:

Article

Massive Post-polypectomy Bleeding in a Patient on Apixaban Reversed with Andexanet Alfa.

Published in:

Digestive Diseases & Sciences, 2023, v. 68, n. 8, p. 3199, doi. 10.1007/s10620-023-07963-9

By:

Bahdi, Firas;
Kaunitz, Jonathan D.

Publication type:

Article

A review of pharmacogenetics of anticoagulant therapy: Heparins, rivaroxaban, apixaban, and dabigatran.

Published in:

Medical Journal of Babylon, 2022, v. 19, n. 3, p. 332, doi. 10.4103/MJBL.MJBL_71_22

By:

Abd Alridha, Ali;
Al-Gburi, Karrar;
Abbood, Sarah

Publication type:

Article

Correction: Arce-Huamani et al. Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis. Medicina 2023, 59 , 1867.

Published in:

2024

By:

Arce-Huamani, Miguel A.;
Barboza, Joshuan J.;
Martínez-Herrera, José Fabián;
Torres-Roman, J. Smith;
Maguiña, Jorge L.

Publication type:

Correction Notice

Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis.

Published in:

Medicina (1010660X), 2023, v. 59, n. 10, p. 1867, doi. 10.3390/medicina59101867

By:

Arce-Huamani, Miguel A.;
Barboza, Joshuan J.;
Martínez-Herrera, José Fabián;
Torres-Roman, J. Smith;
Maguiña, Jorge L.

Publication type:

Article

Cutaneous Ulcer Caused by Apixaban Treatment Is Resolved after Replacement with Dabigatran.

Published in:

Medicina (1010660X), 2022, v. 58, n. 5, p. 691, doi. 10.3390/medicina58050691

By:

Medoro, Alessandro;
Passarella, Daniela;
Mignogna, Donatella;
Porcile, Carola;
Foderà, Emanuele;
Intrieri, Mariano;
Raimo, Gennaro;
La Floresta, Pancrazio;
Russo, Claudio;
Martucci, Gennaro

Publication type:

Article

Apixaban-induced cutaneous hypersensitivity: a case series with evidence of cross-reactivity.

Published in:

2020

By:

Isaq, Nasro A.;
Vinson, Whitney M.;
Rahnama-Moghadam, Sahand

Publication type:

Letter to the Editor